Ramsay Générale de Santé SA (EPA:GDS)
France · Delayed Price · Currency is EUR 9.98
+0.02 (0.20%)
Sep 4, 2025, 3:11 PM CET
Ramsay Générale de Santé Revenue
In the fiscal year ending June 30, 2025, Ramsay Générale de Santé had annual revenue of 5.24B EUR with 4.70% growth.
Revenue
5.24B
Revenue Growth
+4.70%
P/S Ratio
0.21
Revenue / Employee
137.95K
Employees
38,000
Market Cap
1.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 5.24B | 235.50M | 4.70% |
| Jun 30, 2024 | 5.01B | 305.00M | 6.49% |
| Jun 30, 2023 | 4.70B | 400.50M | 9.31% |
| Jun 30, 2022 | 4.30B | 278.40M | 6.92% |
| Jun 30, 2021 | 4.02B | 276.40M | 7.38% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 27.24B |
| Sanofi | 45.74B |
| Sartorius Stedim Biotech | 2.90B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 7.14B |
| Ipsen | 3.76B |
| ABIVAX Société Anonyme | 10.59M |
| Virbac | 1.40B |